drugset / Trial / NCT07334002
The Effects of Conventional Therapy on Tinnitus, Disability, and Quality of Life in Patients With Tinnitus
RandomizedParallel-groupSingle-blindTreatment
Summary
A randomized, single-blind, controlled trial to evaluate the effects of neural therapy on tinnitus severity, disability, and quality of life in patients with tinnitus. The study is planned to be conducted between December 2025 and March 2026. The sample size is 30 patients. The number of centers is 1. The study duration is 3 months.
Timeline
- Start
- 2026-03-01
- Primary completion
- 2026-05-15
- Completion
- 2026-05-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Betahistine | Small molecule | 24 mg | — |